...
机译:脑出血后重新开始口服抗凝剂:缺点
Department of Applied Clinical Sciences and Biotechnology Institute of Neurology University of L’Aquila">(1);
Department of Applied Clinical Sciences and Biotechnology Institute of Neurology University of L’Aquila">(1);
Department of Applied Clinical Sciences and Biotechnology Institute of Neurology University of L’Aquila">(1);
Department of Applied Clinical Sciences and Biotechnology Institute of Neurology University of L’Aquila">(1);
Intracerebral hemorrhage; Atrial fibrillation; Anticoagulants; Thromboembolic risk;
机译:脑出血后重新开始口服抗凝剂:优点
机译:抗凝治疗的安全性,包括急性自发性脑出血患者直接口服抗凝血剂
机译:维生素K和非维生素K拮抗剂口服抗凝药相关的脑出血相似的结果
机译:电阻抗断层扫描的脑出血和二级缺血同时成像
机译:患有机械性心脏瓣膜和颅内出血的患者应重新开始口服抗凝药。
机译:口腔抗凝病剂相关脑出血的反转治疗 - 基于瑞典中风寄存器的观察研究
机译:脑出血后重新开始口服抗凝药:专业